000 01479 a2200361 4500
005 20250513100050.0
264 0 _c19970502
008 199705s 0 0 eng d
022 _a0959-4973
024 7 _a10.1097/00001813-199605000-00007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aD'Alessandro, N
245 0 0 _aIn vivo effects of tumor necrosis factor-alpha or flavone acetic acid in combination with doxorubicin on multidrug-resistant B16 melanoma.
_h[electronic resource]
260 _bAnti-cancer drugs
_cMay 1996
300 _a281-7 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibiotics, Antineoplastic
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Resistance, Multiple
650 0 4 _aDrug Resistance, Neoplasm
650 0 4 _aFemale
650 0 4 _aFlavonoids
_xadministration & dosage
650 0 4 _aMelanoma, Experimental
_xdrug therapy
650 0 4 _aMice
650 0 4 _aSkin Neoplasms
_xdrug therapy
650 0 4 _aTumor Necrosis Factor-alpha
_xadministration & dosage
700 1 _aBorsellino, N
773 0 _tAnti-cancer drugs
_gvol. 7
_gno. 3
_gp. 281-7
856 4 0 _uhttps://doi.org/10.1097/00001813-199605000-00007
_zAvailable from publisher's website
999 _c8788424
_d8788424